Blood Cancer Expert Witnesses

Miami, Florida

Hematology, Oncology - Multiple Myeloma, Immunotherapy, Malignant hematology, Plasma cell dyscrasias, Causation, CAR-T cell therapy, Leukemia, Smoldering, Lymphoma, Stem cell transplant, Amyloidosis, POEMS, Chemotherapy, Blood cancer, Waldenstrom’s macroglobulinemia, MGUS, Bone marrow , Bispecific antibodies, Refractory, Cytogenetics

Dr. Ariel F. Grajales-Cruz, MD is a triple board-certified physician in Internal Medicine, Hematology, and Medical Oncology, internationally recognized for his expertise in multiple myeloma, hematologic malignancies, CAR-T cell therapies, and bispecific antibody treatments. With a strong record in clinical practice, research, and consulting, he is widely sought as a medical expert witness, advisor, and opinion leader. Dr. Grajales-Cruz is an Assistant Member in Malignant Hematology & Cellular Therapy at Moffitt Cancer Center in Tampa, Florida, a leading cancer research institution. His practice focuses on plasma cell disorders, leukemia, lymphoma, and complex blood cancers, with special emphasis on novel immunotherapies. He plays an active role in clinical trial development and real-world evidence studies, bridging patient care and pharmaceutical innovation. In 2022, he founded Grajales Medical Solutions Corp, a consulting practice providing expert medical opinions, litigation suppo...

Wheaton, Illinois

Pediatric Hematology Oncology - Pediatric Hematology Oncology, Pediatric Leukemia, Pediatric Solid Tumors, Blood Cancer, Pediatric Cancer, Acute lymphoblastic leukemia, Acute myeloid leukemia, Anemia, Bone cancer, Brain tumor, Hodgkin lymphoma, Leukemias, Non-Hodgkin lymphoma, Sickle cell anemia, sarcomas

Dr Mittal is a Pediatric Hematologist Oncologist and Associate Professor of Pediatrics at Rush University Medical Center since 2015. She sees patients with all types of pediatric cancers including leukemia, lymphoma, solid cancers and brain tumors as well as benign hematologic conditions. She sees these patients in clinic, infusion room settings for administration of chemotherapy and transfusions and admitted to inpatient floor. She leads and is a co-investigator for various oncology and hematology clinical trials. She leads the Adolescent and Young Adult oncology and AYA Sarcoma programs Notably, she co-established and currently co-directs the Rush AYA Sarcoma Program, and the Musculoskeletal Oncology Service line at Rush Cancer Center. She developed and continues to lead the Pediatric Oncology Survivorship clinic at Rush. Her achievements extend to national and international recognition, with leadership roles in the Children's oncology group (COG) AYA RI Network and various natio...